The company
Harrow, Inc.
HROW · Nasdaq
HROW stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 23.6% below that average now. Pharmaceuticals: 34% of its 74 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 13
- Industry in uptrend
- 34% -5 in 4 wk
- Insider buys, 12 months
- $937K
- Insider sales, 12 months
- $19.3M
- Officials’ trades on record
- 0
- Institutions holding
- 217 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Amir ShojaeiCHIEF SCIENTIFIC OFFICER | sold | 11,250at $40.00 | 14 Aug 2026filed 17 Aug 2026 |
| Lauren P. SilvernailDirector | bought | 1,000at $31.00 | 18 May 2026filed 19 May 2026 |
| Adrienne L. GravesDirector | bought | 1,000at $31.07 | 18 May 2026filed 19 May 2026 |
| Andrew R. BollPRESIDENT AND CFO | bought | 3,500at $29.90 | 14 May 2026filed 15 May 2026 |
| Mark L. BaumCHIEF EXECUTIVE OFFICER | bought | 10,000at $30.20 | 14 May 2026filed 15 May 2026 |
| Opaleye Management Inc.10% owner | sold | 134,000at $39.67 | 4 Mar 2026filed 5 Mar 2026 |
| Opaleye Management Inc.10% owner | sold | 4,263at $39.67 | 4 Mar 2026filed 5 Mar 2026 |
| Opaleye Management Inc.10% owner | sold | 59,000at $39.15 | 3 Mar 2026filed 5 Mar 2026 |
| Opaleye Management Inc.10% owner | sold | 1,309at $39.15 | 3 Mar 2026filed 5 Mar 2026 |
| Opaleye Management Inc.10% owner | sold | 5,000at $54.18 | 27 Feb 2026filed 3 Mar 2026 |
| Opaleye Management Inc.10% owner | sold | 20,000at $53.35 | 6 Jan 2026filed 8 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,740,117$116.4M | +187,358+7.3% |
| Opaleye Management Inc.reduced · filed 14 Aug 2026 | 2,400,000$101.9M | -432,230−15.3% |
| Private Capital Management, LLCadded · filed 14 Aug 2026 | 1,598,770$67.9M | +36,770+2.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,417,212$60.2M | +14,156+1.0% |
| Deep Track Capital, LPnew · filed 14 Aug 2026 | 969,000$41.2M | +969,000 |
| STATE STREET CORPadded · filed 7 Aug 2026 | 939,888$39.9M | +84,841+9.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 905,560$38.5M | +53,526+6.3% |
| BAMCO INCnew · filed 14 Aug 2026 | 809,350$34.4M | +809,350 |
| DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026 | 667,036$28.3M | +87,516+15.1% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 579,127$24.6M | +579,127 |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.